Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 2004; 11(2): 69-71


The Evaluation of Second Trimester Down?s Syndrome Triple Serum Screening Test in Intrauterine Insemination Pregnancies

Birgül Gürbüz*, Serap Yatlı*, Semra Esenkaya*, Handan Sezer*, Samettin Çelik*

.




Abstract


 

Objective: To evaluate second trimester maternal serum total human chorionic gonadotrophin (HCG) , alphafeto

protein (AFP) and unconjugated estriol (uE3) concentration in singleton pregnancies conceived from

intrauterine insemination (IUI)

Material and Methods: Second trimester (16-20 weeks) maternal serum levels of alpha- feto protein (AFP) ,

unconjugated estriol (uE3) and total human chorionic gonadotrophin (hCG) were measured and expressed as

multiples of median (MoM) values in 28 patients conceiving singleton pregnancies by intrauterine insemination

(IUI). The results were compared with those of 82 naturally occuring singleton pregnancies who had serum

screening at 16-20 weeks at the same laboratory over the same period of time.

Results: There were no significant differences between the study and control groups in maternal body weight,

age, gestational week and habitus of cigarette smoking. The median levels of the triple markers were 1.03±0.66

MoM for hCG, 1.09±0.32 MoM for AFP and 1.06±0.01 MoM for uE3 in the IUI pregnancies. The values of

hCG,AFP and uE3 were not significantly different from that in controls. No women were found to be screen

positive. In neither group were chromosomal abnormalities detected and no fetal or neonatal deaths were

recorded.

Conclusions: Based on our findings, IUI did not significantly affect the results of maternal serum Down’s

syndrome screening.

Key Words: Alpha feto protein, Unconjugated estriol , Total human chorionic gonadotrophin, Intrauterine insemination






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.